TMCnet News

Research and Markets: Global Pulmonary Arterial Hypertension (PAH) Market: Trends & Opportunities 2015-2019

[September 01, 2015]

Research and Markets: Global Pulmonary Arterial Hypertension (PAH) Market: Trends & Opportunities 2015-2019

Research and Markets (http://www.researchandmarkets.com/research/wnszd3/global_pulmonary) has announced the addition of the "Global Pulmonary Arterial Hypertension (PAH) Market: Trends & Opportunities (2015-2019)" report to their offering.

The report titled Global PAH Market: Trends and Opportunities (2015-2019), analyzes the potential opportunities and significant trends in the global Pulmonary Arterial Hypertension (PAH) market. The market size and forecast in value terms for global PAH market has been provided for the period 2010 to 2019, considering 2014 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2015 to 2019. Over the next five years, Global PAH market revenue is forecasted to remain stable due to patent expiries and lauch of new drugs.

The report provides detailed analysis of the global PAH market sizing and growth by type for the period 2010-2014. The market is further segment by drug mechanism and different dosage forms. The analysis of PAH individual drugs sales are also provided in the report.

The report profiles key market players such as Actelion Ltd., United Therapeutics Ltd. and SteadyMed Ltd. on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments.

Company Coverage

- Actelion Limited

- United Therapeutics Limited

- SteadyMed Limited

PAH Drug Mechanism

- Endothelin Receptor Antagonists (ERA)

- PDE 5 Inhibitors

- Prostacyclins

- sGC Stimulator

Key Topics Covered:

1. Executive Summary

2. Pulmonary Arterial Hypertension (PAH): An Introduction